Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 16, Issue 3, 2011, Pages 235-245

  Hill, Steven M ^a   Blask, David E ^a   Xiang, Shulin ^a   Yuan, Lin ^a   Mao, Lulu ^a   Dauchy, Robert T ^a   Dauchy, Erin M ^a   Frasch, Tripp ^a   Duplesis, Tamika ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Circadian disruption; Clock; Melatonin; Molecular signaling; Nuclear receptors

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; ESTROGEN RECEPTOR ALPHA; LINOLEIC ACID; MATRIX METALLOPROTEINASE; MELATONIN; MELATONIN 1 RECEPTOR; MESSENGER RNA; MITOGENIC AGENT; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER RISK; CELL PROLIFERATION; CIRCADIAN RHYTHM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; LIGHT EXPOSURE; METASTASIS; MOLECULAR SIGNALING; NIGHT WORK; PROTEIN PHOSPHORYLATION; SHIFT WORKER; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS;

ANIMALS; BREAST; BREAST NEOPLASMS; CIRCADIAN CLOCKS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; MELATONIN; SIGNAL TRANSDUCTION;

EID: 80053552019     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-011-9222-4     Document Type: Article

References (71)

1. Brainard GC, Hanifin JP, Greeson JM, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001;21:6405-12. (Pubitemid 32737772)
2. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295:1070-3. (Pubitemid 34132236)
3. Hastings M, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4:649-61. (Pubitemid 37280160)
4. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005;9:11-24. (Pubitemid 40092915)
5. Reiter RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol. 1991;79:C153-8.
6. Stevens RG, Blask DE, Brainard GC, et al. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect. 2007;115:1357-62. (Pubitemid 47471261)
7. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev. 2009;13:257-64.
8. You S, Wood PA, Xiong Y, et al. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005;91:47-60. (Pubitemid 40684938)
9. Kohsaka A, Bass J. A sense of time: how molecular clocks organize metabolism. Trends Endocrinol Metab. 2007;18:4-11. (Pubitemid 44960013)
10. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005;27:179-88. (Pubitemid 41558450)
11. Hill SM, Blask DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 1988;48:6121-6. (Pubitemid 18266811)
12. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem. 2002;2:113-32.
13. Cos S, Blask DE, Lemus-Wilson A, et al. Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture. J Pineal Res. 1991;10:36-42.
14. Hill SM, Frasch T, Xiang S, et al. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther. 2009;8:337-46.
15. Blask DE, Brainard GC, Dauchy RT, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 2005;65:11174-84. (Pubitemid 41713389)
16. Brydon L, Roka F, Petit L, et al. Dual signaling of human Mel1a melatonin receptors via G (i2), G (i3), and G (q/11) proteins. Mol Endocrinol. 1999;13:2025-38. (Pubitemid 30637264)
17. Lai L, Yuan L, Chen Q, et al. The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation. J Pineal Res. 2008;45:476-88.
18. Collins A, Yuan L, Kiefer TL, et al. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett. 2003;189:49-57. (Pubitemid 35351519)
19. Yuan L, Collins AR, Dai J, et al. MT (1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol. 2002;192:147-56. (Pubitemid 34667233)
20. Lai L, Yuan L, Cheng Q, et al. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat. 2009;118:293-305.
21. Molis TM, Spriggs LL, Hill SM. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol. 1994;8:1681-90.
22. Ram PT, Kiefer T, Silverman M, et al. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol. 1998;141:53-64. (Pubitemid 28393379)
23. Hill SM, Frasch T, Xiang S, Yuan L, et al. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Res. 2009;8:337-46.
24. Del Rio B, Garcia Pedrero JM, Martinez-Campa C, et al. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem. 2004;279:38294-302. (Pubitemid 39295977)
25. Dai J, Inscho EW, Yuan L, et al. Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. J Pineal Res. 2002;32:112-9. (Pubitemid 34289589)
26. Kiefer TL, Lai L, Yuan L, et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res. 2005;38:231-9. (Pubitemid 41475434)
27. Dai J, Ram PT, Yuan L, et al. Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin. Mol Cell Endocrinol. 2001;176:111-20. (Pubitemid 32454942)
28. Lapin V Pineal gland and malignancy. Osterr Z Onkol. 1976;3:51-60.
29. Blask DE. The pineal: an oncostatic gland? In: Rj R, editor. The pineal gland. New York: Raven; 1984. p. 253-84.
30. Cos S, Fernandez R, Guezmes A, et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998;58:4383-90. (Pubitemid 28450041)
31. Leon-Blanco MM, Guerrero JM, Reiter RJ, et al. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res. 2003;35:204-11. (Pubitemid 37100399)
32. Tan M, Yao J, Yu D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 1997;57:1199-205. (Pubitemid 27138623)
33. Schmid BC, Rudas M, Rezniczek GA, et al. CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia. Breast Cancer Res Treat. 2004;84:247-50. (Pubitemid 38445374)
34. Mao L, Slakey LM, Jones FE, Burow ME, Hill SM. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of p38 mitogen-activated protien kinase signaling pathway. Breast Cancer Res. 2010;12:R107 Epub.
35. Kim MS, Lee EJ, Kim HR, et al. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 2003;63:5454-61.
36. Sauer LA, Dauchy RT, Blask DE. Polyunsaturated fatty acids, melatonin, and cancer prevention. Biochem Pharmacol. 2001;61:1455-62. (Pubitemid 32476900)
37. Blask DE, Dauchy RT, Sauer LA et al. Oral melatonin supplementation in rats and a human subject suppresses the growth activity of steroid receptor negative human breast cancer xenografts in female nude rats via an MT1 receptor-mediated suppression of signal tranduction and linoleic acid uptake and metabolism. In: AACR Meeting abstracts; 2005. pp. 1358.
38. Reyes N, Reyes I, Tiwari R, et al. Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett. 2004;209:25-35. (Pubitemid 38625742)
39. Blask DE, Sauer LA, Dauchy RT, et al. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res. 1999;59:4693-701. (Pubitemid 29428978)
40. Wu J, Dauchy RT, Tirrell PC, et al. Light at night activates IGF-R/PDK signaling and accelerates tumor growth in human breast cancer xenografts. Cancer Res. 2011;71:2622-31.
41. Stevens RG Electric power use and breast cancer: a hypothesis. Am J Epidemiol. 1987;125:556-61. (Pubitemid 17047129)
42. Stevens R, London SJ. Breast cancer. In: Stevens RG, Wilson BW, Anderson LE, editors. The melatonin hypothesis: breast cancer and the use of electric power. Columbus: Battelle Press; 1997. p. 9-24.
43. Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 2001;12:279-87. (Pubitemid 32515375)
44. Stevens RG. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol. 2009;38:963-70.
45. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12:74-7. (Pubitemid 32006465)
46. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93:1557-62. (Pubitemid 32998485)
47. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001;93:1563-8. (Pubitemid 32998486)
48. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007;8:1065-6.
49. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;97:1084-7. (Pubitemid 41417926)
50. Kloog I, Stevens RG, Haim A et al. Nighttime light level codistributes with breast cancer incidence worldwide. Cancer Causes Control. 2010;21(12):2059-68.
51. Schernhammer ES, Berrino F, Krogh V, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2008;100:898-905. (Pubitemid 351881952)
52. Dauchy RT, Sauer LA, Blask DE, et al. Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci. 1997;47:511-8.
53. Dauchy RT, Blask DE, Sauer LA, et al. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett. 1999;144:131-6. (Pubitemid 29457654)
54. Cailotto C, Lei J, Van der Vliet J, et al. Effects of nocturnal light on (clock) gene expression in peripheral organs: a role for the autonomic innervation of the liver. PLoS One. 2009;4:e5650.
55. Kennaway DJ, Owens JA, Voultsios A, et al. Metabolic homeostasis in mice with disrupted Clock gene expression in peripheral tissues. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1528-37. (Pubitemid 47535771)
56. Guillaumond F, Dardente H, Giguere V, et al. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms. 2005;20:391-403. (Pubitemid 41318436)
57. Xiang S, Coffelt SB, Mao L, et al. Period-2: a tumor suppressor gene in breast cancer. J Circadian Rhythms. 2008;6:4-12.
58. Yang X, Wood PA, Du-Quiton J, Ansell CM, Hrushesky WJ. Down reguation of circadian clock gene Period 2 accelerates breast cancer growth by alteringit daily growth rhythm. Breast Cancer Res Treat. 2009;117:423-31.
59. Kim E, Yoo Y, Yang W, Lim Y, Na T, Lee I, et al. Transcriptiohnal activation of Hif1 by RORα and its role in hypoxia signaling. Arterioscler Thromb Vasc Biol. 2008;28:1796-802.
60. Xiang S, Mao L, Yuan L, Hill SM. Effect of melatonin on the clock genes in breast epithelial and breast cancer cells. 100th Annual Mtg. American Association for Cancer Research, Denver, CO., Abst. #3596;2009.
61. Fu L, Pelicano H, Liu J, et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111:41-50.
62. Nakahata Y, Kaluzova M, Grimaldi B, et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell. 2008;134:329-40. (Pubitemid 352010336)
63. Liu T, Liu PY, Marshall GM. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 2009;69:1702-5.
64. Hardeland R, Reiter RJ, Poeggeler B, et al. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev. 1993;17:347-57. (Pubitemid 23306320)
65. Poeggeler B, Thuermann S, Dose A, et al. Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs. J Pineal Res. 2002;33:20-30. (Pubitemid 34833071)
66. Matuszak Z, Rezka K, Chignell CF. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Rad Biol Med. 1997;23:367-72. (Pubitemid 27276772)
67. Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res. 1998;25:65-6. (Pubitemid 28319918)
68. Uz T, Manev H. Circadian expression of pineal 5-lipoxygenase mRNA. Neuroreport. 1998;9:783-6. (Pubitemid 28179275)
69. Zhang H, Akbar M, Kim HY. Melatonin: an endogenous negative modulator of 12-lipoxygenatyion in the rat pineal gland. Biochem J. 1999;344:487-93. (Pubitemid 30011606)
70. Hardeland R. Melatonin: multiple functions in signaling and protection. In: Altmeyer P, Hoffman K, Stucker M, editors. Skin Cancer and UV Radiation. Berlin-Heidelberg: Springer; 1997. p. 186-98.
71. Genova ML, Pich MM, Bernacchia A, et al. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann NYAcad Sci. 2004;1011:86-100. (Pubitemid 38608395)